AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award from University of Chicago Booth School of Business

Prestigious recognition for exceptional experienced achievement in the formation of a thriving organization awarded to Booth College of Business Alumni

Investigation TRIANGLE PARK, N.C., June 3, 2022 /PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), an independently operated subsidiary of Bayer AG, now announced that CEO and Co-Founder Sheila Mikhail was recognized by the College of Chicago Booth Faculty of Small business for remarkable expert achievement amid its alumni. As a 1993 finance MBA graduate with honors, Ms. Mikhail has been regarded with the 2022 Entrepreneurial Award.

“This award is tremendously meaningful as the Booth School of Company is a person of the nation’s top ranked business educational institutions,” said AskBio Co-Founder and CEO Sheila Mikhail. “The award is a reflection of the achievements that could not be possible devoid of the assistance of a earth-course crew at AskBio as we proceed to advance our investigate, scientific candidates and production capabilities.”

Ms. Mikhail earned a JD with honors from Northwestern University, a finance MBA with honors from the College of Chicago, and a BS with optimum honors from the University of Illinois at Urbana-Champaign. She co-launched AskBio in 2001 with Dr. R. Jude Samulski, who is regarded a single of the main pioneers for AAV gene treatment technologies.  Considering the fact that co-founding AskBio, and below the leadership of Ms. Mikhail, the business, including its production services, has grown to make use of over 700 biotech pros operating in 5 nations around the world.

Eighteen months following closing a sequence A funding round of $235 million in April 2019, Ms. Mikhail orchestrated a $4 billion acquisition by Bayer AG in Oct 2020.  Below Ms. Mikhail’s leadership, AskBio is flourishing with an expansive gene remedy engineering toolbox, 3 condition-of-the-art manufacturing amenities in San Sebastian Spain and a strong therapeutic pipeline, all at several medical levels, to take care of Pompe Illness, Limbe Girdle Muscular Dystrophy, Several Program Atrophy, Congestive Coronary heart Failure, Huntington’s Ailment, and Parkinson’s Sickness.

“In my perspective, Sheila is a person of the most attained Biotech executives in the business,” commented Dr. Samulski, AskBio’s Co-Founder and Chief Scientific Officer. “The recognition by College of Chicago Booth College of Organization is a testomony of her unparalleled enterprise acumen put together with her considerable command of genetic science”

The Distinguished Alumni awards are only accessible to graduates of Chicago Booth. The Entrepreneurial Award is specified to a person who has demonstrated specialist achievement of the optimum caliber in the administration and formation of a successful business and is recognition by colleagues and peers for superb leadership and administrative capabilities.

About AskBio

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG acquired in 2020, is a totally built-in gene therapy company dedicated to establishing life-conserving medicines that treatment genetic health conditions. The enterprise maintains a portfolio of scientific courses across a array of neuromuscular, central anxious method, cardiovascular and metabolic disorder indications with a scientific-phase pipeline that consists of therapeutics for Pompe sickness, Parkinson’s sickness, and congestive heart failure. AskBio’s gene therapy system includes Professional10™, an field-main proprietary cell line producing approach, and an substantial capsid and promoter library. With worldwide headquarters in Study Triangle Park, North Carolina, and European headquarters in Edinburgh, United kingdom, the firm has generated hundreds of proprietary capsids and promoters, various of which have entered scientific testing. Founded in 2001 and an early innovator in the gene treatment subject, the corporation holds a lot more than 750 patents in spots these as AAV creation and chimeric and self-complementary capsids. Master more at www.askbio.com or follow us on LinkedIn. 

About Bayer

Bayer is a international company with main competencies in the daily life science fields of health and fitness care and nourishment. Its items and expert services are built to help people and the earth prosper by supporting attempts to master the main issues presented by a growing and getting older world-wide inhabitants. Bayer is dedicated to driving sustainable advancement and generating a favourable affect with its firms. At the same time, the Team aims to raise its earning electric power and produce worth by means of innovation and growth. The Bayer brand name stands for have confidence in, reliability, and top quality in the course of the entire world. In fiscal 2021, the Group utilized all over 100,000 persons and experienced sales of 44.1 billion euros. R&D expenses before unique goods amounted to 5.3 billion euros. For more information and facts, visit www.bayer.com. 

AskBio Forward-On the lookout Statements

This press release includes “forward-hunting statements.” Any statements contained in this push launch that are not statements of historical point may possibly be deemed to be forward-on the lookout statements. Text these as “thinks,” “anticipates,” “options,” “expects,” “will,” “intends,” “potential,” “feasible” and equivalent expressions are meant to establish ahead-wanting statements. These forward-looking statements contain with out limitation statements concerning AskBio’s pipeline of progress candidates, producing technological know-how and system. These ahead-searching statements contain risks and uncertainties, several of which are outside of AskBio’s management. Recognized pitfalls include, among the some others: AskBio might not be in a position to execute on its business enterprise plans and plans, like assembly its anticipated or planned regulatory milestones and timelines, its reliance on 3rd-get-togethers, scientific growth options, producing procedures and ideas, and bringing its product or service candidates to sector, owing to a range of good reasons, including the ongoing COVID-19 pandemic, feasible constraints of corporation financial and other means, manufacturing constraints that could not be expected or resolved in a well timed fashion, probable disagreements or other problems with our 3rd-party collaborators and companions, and regulatory, courtroom or company responses or selections, these as opinions and choices from the United States Food and Drug Administration or the United States Patent and Trademark Business. Any of the foregoing dangers could materially and adversely influence AskBio’s organization and effects of functions. You ought to not location undue reliance on the forward-searching statements contained in this push launch. AskBio does not undertake any obligation to publicly update its ahead-seeking statements dependent on situations or situation after the day hereof. 

Perspective initial content to download multimedia:https://www.prnewswire.com/information-releases/askbio-ceo-and-co-founder-sheila-mikhail-gets-2022-entrepreneurial-award-from-college-of-chicago-booth-college-of-small business-301560981.html

Supply AskBio